Tech Company Financing Transactions
Cellular Genomics Funding Round
On 6/14/2004, Cellular Genomics announced $34.9 million in Series C funding from RiverVest Venture Partners, Coastview Capital and Flagship Pioneering.
Transaction Overview
Company Name
Announced On
6/14/2004
Transaction Type
Venture Equity
Amount
$34,900,000
Round
Series C
Investors
RiverVest Venture Partners (Lead Investor) (Mark Mendel)
Proceeds Purpose
The capital raised in this round will allow us to advance into the clinic our novel drug development programs in several major therapeutic areas.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
36 East Industrial Rd.
Branford, CT 06405
USA
Branford, CT 06405
USA
Phone
Website
Email Address
Overview
Cellular Genomics Inc. is a privately held genomics-based biopharmaceutical company that is pioneering a unique, highly integrated chemical genetics platform to discover and develop kinase and other signal transduction inhibitors for multiple clinical indications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Muzammil Mansuri
Chief Operating Officer
Peter Fuller
Chief Scientific Officer
David Armistead
Vice President
Mark Velleca
Browse more venture capital transactions:
Prev: 6/14/2004: Medidata Solutions venture capital transaction
Next: 6/14/2004: Chroma Therapeutics venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs